Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Delian Zhou"'
Publikováno v:
Experimental Hematology & Oncology, Vol 13, Iss 1, Pp 1-12 (2024)
Abstract Chimeric antigen receptor-T cell therapy, a groundbreaking cancer treatment, has achieved remarkable success against hematologic malignancies. However, CAR-T monotherapy faces challenges in certain cases, including treatment tolerance and re
Externí odkaz:
https://doaj.org/article/f328d036fd1b4482a0a90bd11f67b176
Publikováno v:
Cancer Medicine, Vol 13, Iss 11, Pp n/a-n/a (2024)
Abstract Chimeric antigen receptor T‐cell (CAR‐T) therapy is becoming an effective technique for the treatment of patients with relapsed/refractory hematologic malignancies. After analyzing patients with tumor progression and sustained remission
Externí odkaz:
https://doaj.org/article/7d2b0559f6314471904be29d615c780b
Publikováno v:
Therapeutic Advances in Hematology, Vol 15 (2024)
Lymphoma occurring in the central nervous system is considered primary central nervous system lymphoma (PCNSL), usually without systematic lesions. Over the last few decades, a deep understanding of PCNSL has been lacking due to the low incidence rat
Externí odkaz:
https://doaj.org/article/992c9c6595584457bafc718afd570bb2
Autor:
Wanying Liu, Jiaying Wu, Xi Ming, Qi Zhang, Delian Zhou, Rubing Zheng, Mi Zhou, Zhen Shang, Liting Chen, Xiaojian Zhu, Yi Xiao
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundAnaplastic lymphoma kinase-positive anaplastic large cell lymphoma (ALK+ ALCL) is a rare, mature T-cell non-Hodgkin lymphoma. The prognosis of patients with relapsed or refractory ALCL following first-line chemotherapy is extremely poor. NC
Externí odkaz:
https://doaj.org/article/670b8ebdf3d24f63a873049128a9e729